stock repurchase 4basebio Announces Treasury Share Buyback The company recently changed its name from Expedeon following the sale of its immunology and proteomics businesses to Abcam. Bruker Authorizes $300M Share Repurchase Program The company also announced that its board of directors has authorized payment of a quarterly cash dividend of $0.04 per share of its common stock. Qiagen Q1 Revenues Grow 2 Percent Qiagen also announced plans to launch a new $100 million share repurchase program after completing its current $200 million share repurchase commitment. Myriad Genetics to Repurchase $50M in Shares From Bank of America The company has entered into an accelerated share repurchase program with the bank to buy back a portion of its common stock. Thermo Fisher to Repurchase $2B of its Shares, Acquire BD's Advanced Bioprocessing Business The BD business, which has annual revenues of about $100 million, offers technical services as well as peptones for cell culture media used in biopharmaceutical applications. Nov 28, 2017 Bio-Rad Authorizes $250M Share Repurchase Program Jan 18, 2017 Qiagen Details $250M Synthetic Share Repurchase Plan Aug 15, 2016 Qiagen Announces $250M Synthetic Share Repurchase Program Aug 4, 2016 PerkinElmer Q2 Revenues Up 2 Percent; Discloses Bioo Scientific Acquisition Jun 7, 2016 Myriad Genetics Adds $200M to Share Repurchase Program Nov 13, 2015 Thermo Fisher Announces $1B Share Repurchase Plan Nov 13, 2015 Bruker Board OKs $225M Share Repurchase Program Nov 2, 2015 Illumina Launches $250M Share Repurchase Program May 28, 2015 Agilent Board Approves $1.14B Share Buyback Program May 22, 2015 Bruker Authorizes Share Buyback Program May 13, 2015 Qiagen Repurchasing up to $30M of Shares Feb 24, 2015 Myriad Board OKs $200M Share Repurchase Program Aug 6, 2014 Waters Discloses $23M Price Tag for MediMass Technology; New Share Buyback Program Approved Nov 22, 2013 Agilent Board Authorizes Share Repurchase Program, Dividend Sep 12, 2013 Qiagen Initiates Buyback of $10M of Shares Jul 31, 2013 UPDATE: Qiagen Revenues up 3 Percent in Q2; Plans $100M Stock Buyback Apr 23, 2013 Quest Enters into Agreement to Buy Back $450M of Stock Jan 17, 2013 Agilent to Undertake $500M Share Repurchase, Increases Dividend Dec 11, 2012 Genomic Health's Board Approves $30M Share Repurchase Program Sep 24, 2012 Qiagen Initiating First Tranche of Share Buyback Program; Repurchasing $10M of Shares Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.